Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sherman

Showing results (771-780 of 825) with videos related to

Pageof 83
Sort By:
Journal of Neuro-Oncology|June 14, 2022
The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter studyAndres Ramos-Fresnedo, Ricardo A Domingo, Carlos Perez-Vega, et al.
Menopause (New York, N.Y.)|September 19, 2013
Efficacy of yoga for vasomotor symptoms: a randomized controlled trialKatherine M Newton, Susan D Reed, Katherine A Guthrie, et al.
Journal of Neurosurgery|November 19, 2021
The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experienceAndres Ramos-Fresnedo, Ricardo A Domingo, Jesus E Sanchez-Garavito, et al.
Neurosurgery Practice|February 17, 2025
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial ProtocolAndres Ramos-Fresnedo, Rawan Al-Kharboosh, Erin L Twohy, et al.
Neurosurgery Practice|March 11, 2024
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial ProtocolAndres Ramos-Fresnedo, Rawan Al-Kharboosh, Erin L Twohy, et al.
Iscience|June 30, 2025
Angiotensin AT<sub>1</sub>R expressing cells within the ventral hypothalamus modulate integrative control of cardiometabolic functionsJhonatan Pasos, Valerie A Wagner, Samuel B R Lawton, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2010
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experienceJeremy Setton, Nicola Caria, Jonathan Romanyshyn, et al.
Cancer|February 26, 2020
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignanciesMing Fan, Jung Julie Kang, Anna Lee, et al.
Neuro-Oncology Advances|July 1, 2026
Defining rapid early progression in glioblastoma-A volumetric approachVikram Munlapudi, Jacob Guzzino, David J Crompton, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2022
Osteoporosis identification among previously undiagnosed individuals with vertebral fracturesL S Gold, R F Cody, W K Tan, et al.
Pageof 83

Showing results (771-780 of 825) with videos related to

Sort By:
Pageof 83
Journal of Neuro-Oncology|June 14, 2022
The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter studyAndres Ramos-Fresnedo, Ricardo A Domingo, Carlos Perez-Vega, et al.
Menopause (New York, N.Y.)|September 19, 2013
Efficacy of yoga for vasomotor symptoms: a randomized controlled trialKatherine M Newton, Susan D Reed, Katherine A Guthrie, et al.
Journal of Neurosurgery|November 19, 2021
The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experienceAndres Ramos-Fresnedo, Ricardo A Domingo, Jesus E Sanchez-Garavito, et al.
Neurosurgery Practice|February 17, 2025
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial ProtocolAndres Ramos-Fresnedo, Rawan Al-Kharboosh, Erin L Twohy, et al.
Neurosurgery Practice|March 11, 2024
Phase 1, Dose Escalation, Nonrandomized, Open-Label, Clinical Trial Evaluating the Safety and Preliminary Efficacy of Allogenic Adipose-Derived Mesenchymal Stem Cells for Recurrent Glioblastoma: A Clinical Trial ProtocolAndres Ramos-Fresnedo, Rawan Al-Kharboosh, Erin L Twohy, et al.
Iscience|June 30, 2025
Angiotensin AT<sub>1</sub>R expressing cells within the ventral hypothalamus modulate integrative control of cardiometabolic functionsJhonatan Pasos, Valerie A Wagner, Samuel B R Lawton, et al.
International Journal of Radiation Oncology, Biology, Physics|December 21, 2010
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experienceJeremy Setton, Nicola Caria, Jonathan Romanyshyn, et al.
Cancer|February 26, 2020
Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignanciesMing Fan, Jung Julie Kang, Anna Lee, et al.
Neuro-Oncology Advances|July 1, 2026
Defining rapid early progression in glioblastoma-A volumetric approachVikram Munlapudi, Jacob Guzzino, David J Crompton, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 2, 2022
Osteoporosis identification among previously undiagnosed individuals with vertebral fracturesL S Gold, R F Cody, W K Tan, et al.
Pageof 83